improve diagnosis and treatment of UTIs. In response to antibiotics losing their power, researchers are trying to repurpose existing drugs or increase their penetration into the tissues where they’re needed. Last year, pharmaceutical company GSK also reported promising test results for a new oral antibiotic. If approved, it would be the first one developed in over two decades to treat uncomplicated UTIs.
